A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
Clinical trial NCT05353192 · COMPLETED
Trial details
- NCT number
- NCT05353192
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-20
- Primary completion
- 2025-08-25
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.